{
    "clinical_study": {
        "@rank": "147796", 
        "arm_group": [
            {
                "arm_group_label": "Plenadren", 
                "description": "Modified release hydrocortisone"
            }, 
            {
                "arm_group_label": "Other Glucocorticoid Replacement Therapy"
            }
        ], 
        "brief_summary": {
            "textblock": "As a post-approval requirement of the European Medicines Agency, this European patient\n      registry is an observational study being conducted to monitor the safety of long-term\n      treatment with Plenadren and other glucocorticoid replacement therapies in routine clinical\n      practice in patients with chronic adrenal insufficiency (primary or secondary)."
        }, 
        "brief_title": "A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency", 
        "condition": "Chronic Adrenal Insufficiency", 
        "condition_browse": {
            "mesh_term": [
                "Addison Disease", 
                "Adrenal Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of chronic adrenal insufficiency\n\n          -  Written informed consent/assent in compliance with applicable country-specific and\n             local regulations\n\n        Exclusion Criteria:\n\n          -  Participation in an interventional clinical trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with chronic adrenal insufficiency (primary or secondary) who are receiving\n        Plenadren or other glucocorticoid replacement therapies at endocrinology centres in\n        certain European countries as part of their routine clinical care.  Approximately 20 sites\n        are planned for enrollment."
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01661387", 
            "org_study_id": "Protocol 0918-400"
        }, 
        "intervention_browse": {
            "mesh_term": "Hydrocortisone"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Adrenal insufficiency", 
            "Congenital adrenal hyperplasia (CAH)", 
            "Hydrocortisone", 
            "Modified release", 
            "DuoCort"
        ], 
        "lastchanged_date": "May 6, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "ViroPharma Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Erlangen", 
                        "country": "Germany"
                    }, 
                    "name": "ViroPharma Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt", 
                        "country": "Germany"
                    }, 
                    "name": "ViroPharma Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany"
                    }, 
                    "name": "ViroPharma Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuerzburg", 
                        "country": "Germany"
                    }, 
                    "name": "ViroPharma Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gothenburg", 
                        "country": "Sweden"
                    }, 
                    "name": "ViroPharma Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Linkoping", 
                        "country": "Sweden"
                    }, 
                    "name": "ViroPharma Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United Kingdom"
                    }, 
                    "name": "ViroPharma Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leeds", 
                        "country": "United Kingdom"
                    }, 
                    "name": "ViroPharma Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }, 
                    "name": "ViroPharma Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manchester", 
                        "country": "United Kingdom"
                    }, 
                    "name": "ViroPharma Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newcastle", 
                        "country": "United Kingdom"
                    }, 
                    "name": "ViroPharma Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oxford", 
                        "country": "United Kingdom"
                    }, 
                    "name": "ViroPharma Investigational Site"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Germany", 
                "Sweden", 
                "United Kingdom"
            ]
        }, 
        "number_of_groups": "2", 
        "official_title": "A European, Multi-Centre, Multi-Country, Post-Authorisation, Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency", 
        "overall_contact": {
            "email": "protocol-0918-400@viropharma.com", 
            "last_name": "Veerle Hufkens", 
            "phone": "+32 2 304 1987"
        }, 
        "overall_official": {
            "affiliation": "ViroPharma", 
            "last_name": "Gwendolyn Niebler, DO", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United Kingdom: National Health Service", 
                "Germany: Ethics Commission", 
                "Sweden: Institutional Review Board", 
                "Sweden: Regional Ethical Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Incidence of intercurrent illness", 
                "safety_issue": "Yes", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "Incidence of adrenal crisis", 
                "safety_issue": "Yes", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "Incidence of serious adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "5 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01661387"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Shire", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shire", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}